Investigating the Effect of Vitamins E, C and D on Symptoms of Withdrawal Syndrome

Phase 3

• Conditions: Anxiety and pain caused by drug withdrawal in addicted patients.; Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances; F19.3

• Registration Number: IRCT20200721048159N6
• Lead Sponsor: Khoram-Abad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 125

Inclusion Criteria

Confirmed diagnosis of opioids and stimulants substances
Men over 18 years old
The emergence of withdrawal syndrome based on the diagnosis of a psychiatrist
a score of at least 3 in the VAS test
Performing a TLC test to detect consumption (methadone, morphine, amphetamine and etc..)
Consent to participating in the study

Exclusion Criteria

Taking multivitamin, mineral and antioxidant supplements in the last 3 months before starting the intervention
Liver or kidney failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain caused by drug withdrawal according to VAS test. Timepoint: Before the start of the intervention and daily for ten days after the start of the intervention. Method of measurement: Test VAS.;Examining anxiety caused by quitting addiction. Timepoint: Before the start of the intervention and daily for ten days after the start of the intervention. Method of measurement: Beck's anxiety questionnaire.